Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds eukaryotic cell or component thereof or substance...
Patent
1998-03-23
2000-06-20
Burke, Julie
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds eukaryotic cell or component thereof or substance...
514 2, 5303871, 5303877, 5303879, 5303881, 53038815, 53038822, 424 96, 424 133, 424 169, 424 149, G01N 3353, A61K 39395
Patent
active
060775084
ABSTRACT:
The present invention relates to the use of molecules capable of specifically binding a urokinase plasminogen activator receptor (uPAR) as diagnostic reagents for the detection of metastases in vivo. Such metastases can include, but are not limited to, micrometastases.
REFERENCES:
patent: 4782840 (1988-11-01), Martin, Jr. et al.
patent: 5015571 (1991-05-01), Niman et al.
patent: 5189014 (1993-02-01), Cowan, Jr.
patent: 5225539 (1993-07-01), Winter
patent: 5383456 (1995-01-01), Arnold et al.
patent: 5441050 (1995-08-01), Thurston et al.
patent: 5519120 (1996-05-01), Dan.o slashed.
patent: 5585089 (1996-12-01), Queen
patent: 5679350 (1997-10-01), Jankun et al.
Rabbani, S.A. Urokinase receptor directed immunodiagnostic and immunotherapeutic strategies for prstate and breast cancer, Proceedings of the American Association for Cancer Research, vol. 38, p. 249, Mar. 21, 1997.
Andreasen et al., 1997, "The Urokinase-Type Plasminogen Activator System in Cancer Metastasis: A Review", Int. J. Cancer 72:1-22.
Appella et al., 1987, "The Receptor-Binding Sequence of Urokinase", J. Biol. Chem. 262:4437-4440.
Chucholowski et al., 1992, "Flow Cytofluorometric Analysis of the Urokinase Receptor (uPAR) on Tumor Cells by Fluorescent uPA-Ligand or Monoclonal Antibody #3936", Fibrinolysis 6(suppl. 4):95-102.
deVries et al., 1994, "Plasminogen Activators, Their Inhibitors, and Urokinase Receptor Emerge in Late Stages of Melanocytic Tumor Progression", Am. J. Path. 144:70-81.
Jankun et al., 1993, "Expression and Localization of Elements of the Plasminogen Activator System in Benign Breast Disease and Breast Cancers", J. Cell. Biochem. 53:135-144.
Jankun, 1993, "The Urokinase Plasminogen Activator Pathway as a Novel Mechanism of Tumor Targeting and Cell Membrane Traversal", J. Cell. Biochem. Suppl. 17C:33 (abstr. H242).
Liotta et al., 1991, "Cancer Metastasis and Angiogenesis: An Imbalance of Positive and Negative Regulation", Cell 64:327-336.
Liotta, 1986, "Tumor Invasion and Metastases--Role of the Extracellular Matric: Rhoads Memorial Award Lecture", Cancer. Res. 46:1-7.
Mundy, 1997, "Mechanisms of Bone Metastasis", Cancer (suppl.) 80:1546-1556.
Presta et al., 1997, "Humanization of an Anti-Vascular Endothelial Growth Factor Monoclonal Antibody for the Therapy of Solid Tumors and Other Disorders", Cancer Res. 57:4593-4599.
Pyke et al., 1995, "Lamin-5 is a Marker of Invading Cancer Cells in Some Human Carcinomas and is Coexpressed with the Receptor for Urokinase Plasminogen Activator in Budding Cancer Cells in Colon Adenocarcinomas", Cancer Res. 55:4132-4139.
Rabbani, 1997, "Urokinase Receptor Directed Immunodiagnostic and Immunotherapeutic Strategies for Prostate and Breast Cancer", Proc. Am. Assoc. Cancer Res. 38:249 (abstr. 1673).
Rabbani et al. 1994, "Isolation and Characterization of Multiple Isoforms of the Rat Urokinase Receptor in Osteoblasts", FEBS Lett. 338:69-74.
Rabbani et al., 1992, "Structural Requirements for the Growth Factor Activity of the Amino-Terminal Domain of Urokinase", J. Biol. Chem. 267:14151-14156.
Schmitt et al., 1997, "Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy", Thrombosis and Haemostasis 78:285-296.
Will et al., 1994, "Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Ovarian Cancer Cells and in vitro Invasion Capacity", Intl. J. Oncology 5:753-761.
Xing and Rabbani, 1996, "Role of Urokinase Receptor in Breast Cancer Invasion and Metastasis: Potential Therapeutic Strategies", Proc. Am. Assoc. Cancer Res. 37:90 (abstr. 626).
Xing and Rabbani, 1996, "Overexpression of Urokinase Receptor in Breast Cancer Cells Results in Increased Tumor Invasion, Growth and Metastasis", Int. J. Cancer 67:423-429.
Hart Richard
Rabbani Shafaat A.
American Diagnostica Inc.
Burke Julie
McGill University
LandOfFree
Urokinase plasminogen activator receptor as a target for diagnos does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urokinase plasminogen activator receptor as a target for diagnos, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urokinase plasminogen activator receptor as a target for diagnos will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849746